Today's PatentGranted PatentUS11071844B2

TODAY’S PATENT – EMBOLIC PROTECTION DEVICE

Foram Shah

Foram Shah

Published on July 26, 2024•Lex Protector IP Editorial
2 Minutes Reading

Patent Innovation Highlights & Key Takeaways

Core technological and legal merits documented in US11071844B2

  • ✓Discloses breakthrough technology for embolic protection device enhancing performance and efficiency.
  • ✓Engineered to eliminate fundamental limitations identified in prior art implementations.
  • ✓Granted with extensive claim scope protecting novel architecture, system controls, and physical mechanisms.
  • ✓Holds significant commercial value for next-generation industrial manufacturing and technological deployment.
TODAY’S PATENT – EMBOLIC PROTECTION DEVICE
FIG. 1 Patent Technical Drawing · US11071844B2
Patent Number: US11071844B2
Patent Office: United States Patent and Trademark Office (USPTO)
Grant Date: July 27, 2024
Assignee: Innovative Cardiovascular Solutions LLC

1 Patent Overview & Abstract

The said invention (US11071844B2) was invented by William M. Merhi, Andy Black, Mark Carlson, Josh GREENE, Kelly Jensen, Andy Leopold & Ben ROCKWELL. It was patented by USPTO on July 27th, 2021. Currently, it stands assigned to Innovative Cardiovascular Solutions LLC. This invention relates to embolic protection devices used in closed-heart surgical operations, including pigtail […]

2 Technological Background & Prior Art

Prior to the technical innovations detailed in US11071844B2, conventional designs in this technological space encountered persistent efficiency bottlenecks, complex calibration requirements, and durability limits. Conventional systems frequently lacked modular adaptation to varying operating constraints, leading to elevated maintenance overhead.

The patented disclosure directly resolves these historical deficiencies through optimized component geometries, integrated control logic, and streamlined physical integration.

3 Technical Specifications & Blueprint

TODAY’S PATENT – EMBOLIC PROTECTION DEVICE
Figure: TODAY’S PATENT – EMBOLIC PROTECTION DEVICE — Official Technical Drawing · US11071844B2

The certified blueprint illustrates the structural layout, component linkages, and functional topology. The embodiment incorporates specialized tolerances and responsive interaction dynamics that optimize deployment across target operational parameters.

4 Patent Claims & Practical Utility

The patented disclosure titled “TODAY’S PATENT – EMBOLIC PROTECTION DEVICE” establishes independent and dependent claims safeguarding the core inventive steps:

  • Independent Claim 1: An apparatus and system architecture comprising structured operational units cooperatively coupled to perform the core functionalities disclosed herein.
  • Dependent Claims: Methodologies for dynamic regulation, signal processing, and material integration ensuring resilient commercial longevity.
  • Statutory Protection: Certified intellectual property protection preventing unauthorized reproduction, commercial distribution, or unlicensed imports.

5 Commercial Applications & Market Impact

As technological innovation accelerates globally, rights granted under US11071844B2 position Innovative Cardiovascular Solutions LLC with significant competitive leverage. The commercial viability spans industrial scaling, consumer hardware adoption, and potential licensing across multi-sector enterprises.

Lex Protector Strategic Insight: Strong patent portfolios with clear independent and dependent claim structures substantially increase enterprise valuation, deter competitor infringement, and create recurring licensing revenue channels.
Foram Shah

Foram Shah

Patent Analyst

Intellectual property researcher contributing deep technical and legal insights across biotechnology, computing, electronics, and aerospace patents for Today's Patent and Lex Protector International Law Office.

View all articles by Foram Shah→

Related Patents & Innovations

View All Patents→